Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
ai-news-today-january-5-2026-top-ai-news-and-breakthroughs
https://artificialintelligence-newstoday.com/ai-news-today-january-5-2026-top-ai-news-and-breakthroughs
artificialintelligence-newstoday.com
|
— | 0 | 6 |
Insilico Medicine
https://insilico.com/blog/first_phase2
NOFOLLOW
|
|
la-revolucion-de-la-inteligencia-artificial
https://www.fundacionbankinter.org/noticias/la-revolucion-de-la-inteligencia-artificial
fundacionbankinter.org
|
58 | 60 | 1,301 |
Insilico Medicine
https://insilico.com/
DOFOLLOW
|
|
insilico-medicine-receives-ind-approval-from-fda-for-ism8...
https://upalpha.com/biotech/insilico-medicine-receives-ind-approval-from-fda-for-ism8969-an-ai-empowered-potential-best-in-class-nlrp3-inhibitor
upalpha.com
|
— | 0 | 9 |
www.insilico.com
http://www.insilico.com/
NOFOLLOW
|
|
wordpress
https://gingercatsoftware.com/wordpress?m=202405
gingercatsoftware.com
|
— | 0 | 37 |
website
https://insilico.com/
DOFOLLOW
|
|
ai-in-pharma
https://www.polestaranalytics.com/blog/ai-in-pharma
polestaranalytics.com
|
44 | 3 | 79 |
(As seen with Insilco’s AI-designed anti-fibrotic drug, which reached phase 1 trials in just 30 months—half the usual time and at a fraction of the typical cost)
https://insilico.com/phase1
DOFOLLOW
|
|
insilico-medicine-nominates-ism5059-the-peripheral-restri...
https://laotiantimes.com/2026/02/05/insilico-medicine-nominates-ism5059-the-peripheral-restricted-nlrp3-inhibitor-as-preclinical-candidate-for-the-treatment-of-multiple-inflammatory-and-metabolism-indications
laotiantimes.com
|
73 | 147 | 277 |
www.insilico.com
https://www.insilico.com/
NOFOLLOW
|
|
top-10-drug-discovery-2025
https://www.aimedapps.com/blog/top-10-drug-discovery-2025
aimedapps.com
|
8 | 3 | 242 |
Visit Website
https://insilico.com/
DOFOLLOW
|
|
ai-driven-drug-development
https://develop.freethink.com/health/ai-driven-drug-development
develop.freethink.com
|
— | 0 | 1,265 |
INS018_055
https://insilico.com/blog/ipf-phase1
DOFOLLOW
|
|
paq-therapeutics-announces-collaboration-with-insilico-me...
https://www.paqtx.com/news/paq-therapeutics-announces-collaboration-with-insilico-medicine-to-develop-novel-therapies-through-autophagy-dependent-degradation
paqtx.com
|
— | 0 | 3 |
www.insilico.com
http://www.insilico.com/
DOFOLLOW
|
|
Insilico-Medicine-and-Hygtia-Therapeutics-Enter-New-Globa...
https://news.taiwannet.com.tw/c8/193154/Insilico-Medicine-and-Hygtia-Therapeutics-Enter-New-Global-Strategic-Collaboration-to-Co-Develop-Novel-Brain-Penetrant-NLRP3-Inhibitor-for-CNS-Diseases-treatment.html
news.taiwannet.com.tw
|
66 | 29 | 156 |
http://www.insilico.com/
NOFOLLOW
|
|
how-ai-is-slashing-drug-discovery-and-development-costs-a...
https://blog.bestai.com/how-ai-is-slashing-drug-discovery-and-development-costs-a-new-era-in-pharmaceutical-innovation
blog.bestai.com
|
7 | 2 | 112 |
https://insilico.com
https://insilico.com/?ref=blog.bestai.com
DOFOLLOW
|
|
268638
https://www.alphagalileo.org/en-gb/Item-Display/ItemId/268638?returnurl=https://www.alphagalileo.org/en-gb/Item-Display/ItemId/268638
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
drug-discovery-informatics-market-2461
https://www.kingsresearch.com/ru/report/drug-discovery-informatics-market-2461
kingsresearch.com
|
21 | 107 | 349 |
Медицина Инсайки
https://insilico.com/
DOFOLLOW
|
|
209793
https://www.alphagalileo.org/en-gb/Item-Display/ItemId/209793?returnurl=https://www.alphagalileo.org/en-gb/Item-Display/ItemId/209793
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
integem.com
|
16 | 21 | 128 |
Insilico Medicine and Qilu Pharmaceutical Launch $120 Million AI Drug Discovery Pact
https://insilico.com/news/ckvxca1tu1-insilico-medicine-and-qilu-pharmaceutica
DOFOLLOW
|
|
an-interview-with-reason-at-undoing-aging-2019
https://www.fightaging.org/archives/2019/08/an-interview-with-reason-at-undoing-aging-2019
fightaging.org
|
64 | 91 | 1,066 |
In Silico Medicine
https://www.insilico.com/
DOFOLLOW
|
|
exc-hunter-bidens-chinese-private-equity-firm-invested-in...
https://warroom.org/exc-hunter-bidens-chinese-private-equity-firm-invested-in-pfizer-partner-developing-covid-19-drugs
warroom.org
|
72 | 126 | 136 |
treatments
https://insilico.com/insiliconanome
DOFOLLOW
|
|
exc-hunter-bidens-chinese-private-equity-firm-invested-in...
https://warroom.org/exc-hunter-bidens-chinese-private-equity-firm-invested-in-pfizer-partner-developing-covid-19-drugs
warroom.org
|
72 | 126 | 136 |
mission
https://insilico.com/about
DOFOLLOW
|
|
exc-hunter-bidens-chinese-private-equity-firm-invested-in...
https://warroom.org/exc-hunter-bidens-chinese-private-equity-firm-invested-in-pfizer-partner-developing-covid-19-drugs
warroom.org
|
72 | 126 | 136 |
search
https://insilico.com/ncov-sprint
DOFOLLOW
|
|
ItemId
https://www.alphagalileo.org/en-gb/Item-Display/ItemId/201976/returnurl/en-gb/Item-Display/ItemId
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
65250
https://aait.co.jp/archives/65250
aait.co.jp
|
11 | 1 | 21 |
www.insilico.com
https://www.insilico.com/
DOFOLLOW
|
|
metformin
https://www.mishablagosklonny.com/tag/metformin
mishablagosklonny.com
|
— | 0 | 453 |
Insilico Medicine, Inc.
https://insilico.com/
DOFOLLOW
|
|
top-25-game-changing-technologies-of-2025-startups-to-watch
https://www.tractiontechnology.com/blog/top-25-game-changing-technologies-of-2025-startups-to-watch
tractiontechnology.com
|
11 | 7 | 118 |
Insilico Medicine
https://insilico.com/
DOFOLLOW
|
|
dr-ren-feng-appointed-as-chief-scientific-officer-of-insi...
https://www.prnewswire.com/news-releases/dr-ren-feng-appointed-as-chief-scientific-officer-of-insilico-medicine-301232551.html?tc=eml_cleartime&utm_campaign=pccrelease&utm_medium=pcc&utm_source=pressrelease
prnewswire.com
|
88 | 22,459 | 43 |
http://insilico.com
http://insilico.com/
NOFOLLOW
|
|
dr-ren-feng-appointed-as-chief-scientific-officer-of-insi...
https://www.prnewswire.com/news-releases/dr-ren-feng-appointed-as-chief-scientific-officer-of-insilico-medicine-301232551.html?tc=eml_cleartime&utm_campaign=pccrelease&utm_medium=pcc&utm_source=pressrelease
prnewswire.com
|
88 | 22,459 | 43 |
www.insilico.com/platform/
http://www.insilico.com/platform
NOFOLLOW
|
|
insilico-medicine-announce-us888-million-multi-year-colla...
https://www.prnewswire.com/news-releases/insilico-medicine-announce-us888-million-multi-year-collaboration-with-servier-for-drug-discovery-and-development-in-oncology-302652132.html
prnewswire.com
|
88 | 22,459 | 43 |
www.insilico.com
https://www.insilico.com/
NOFOLLOW
|
|
insilico-medicine-announce-us888-million-multi-year-colla...
https://www.prnewswire.com/news-releases/insilico-medicine-announce-us888-million-multi-year-collaboration-with-servier-for-drug-discovery-and-development-in-oncology-302652132.html
prnewswire.com
|
88 | 22,459 | 43 |
http://insilico.com/
NOFOLLOW
|
|
ItemId
https://www.alphagalileo.org/es-es/Item-Display-es-ES/ItemId/251061/returnurl/es-es/Item-Display-es-ES/ItemId
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
Login-Details
https://www.alphagalileo.org/en-gb/Login-Details?returnurl=/en-gb/Item-Display/ItemId/201679?returnurl=/en-gb/Item-Display/ItemId/201679
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
weekly-techbio-highlights-69-big
https://www.techlifesci.com/p/weekly-techbio-highlights-69-big
techlifesci.com
|
7 | 2 | 174 |
Insilico Medicine
https://insilico.com/news/insilico-medicine-integrates-nach01-foundation-model-with-microsoft-discovery
DOFOLLOW
|
|
insilico-medicines-latest-ai-engineered-drug-ism5411-coul...
https://www.medicaldesignsourcing.com/insilico-medicines-latest-ai-engineered-drug-ism5411-could-provide-a-novel-approach-for-treating-ibd
medicaldesignsourcing.com
|
12 | 6 | 199 |
an internal pipeline
https://insilico.com/pipeline
DOFOLLOW
|
|
PMC9836757
https://pmc.ncbi.nlm.nih.gov/articles/PMC9836757?ref=newsletters.qs.com
pmc.ncbi.nlm.nih.gov
|
88 | 22,945 | 16,646 |
https://insilico.com/
https://insilico.com/
DOFOLLOW
|
|
fr-fr
https://www.alphagalileo.org/fr-fr
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
Login-Details
https://www.alphagalileo.org/en-gb/Login-Details?returnurl=/en-gb/Item-Display/ItemId/223958?returnurl=/en-gb/Item-Display/ItemId/223958
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
true
https://www.alphagalileo.org/en-gb/Item-Display/ItemId/263939/identifier/18733/alert/true?returnurl=https://www.alphagalileo.org/en-gb/Item-Display/ItemId/263939/identifier/18733/alert/true
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
als-canada-research-update-september-2022
https://als.ca/news/als-canada-research-update-september-2022
als.ca
|
70 | 68 | 185 |
Insilco Medicine
https://insilico.com/
DOFOLLOW
|
|
the-silicon-valley-time-machine-why-ais-cloud-economics-a...
https://www.p05.org/the-silicon-valley-time-machine-why-ais-cloud-economics-are-pushing-biotech-back-to-the-mainframe-era
p05.org
|
— | 0 | 774 |
Pharma.AI platform
https://www.insilico.com/pharma_ai?ref=p05.org
DOFOLLOW
|
|
230046
https://www.alphagalileo.org/fr-fr/Item-Display-fr-FR/ItemId/230046?returnurl=https://www.alphagalileo.org/fr-fr/Item-Display-fr-FR/ItemId/230046
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
UserRegistration
https://www.alphagalileo.org/en-gb/UserRegistration?returnurl=/de-de/Item-Display-de-DE/ItemId/214547??returnurl=https://www.alphagalileo.org/en-gb/Item-Display/ItemId/214547?
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
biotarget-2019-final---pitch-event
https://www.science-entrepreneur.com/event/biotarget-2019-final---pitch-event
science-entrepreneur.com
|
13 | 4 | 92 |
https://insilico.com/
https://insilico.com/
DOFOLLOW
|
|
256351
https://www.alphagalileo.org/en-gb/Item-Display/ItemId/256351?returnurl=https://www.alphagalileo.org/en-gb/Item-Display/ItemId/256351
alphagalileo.org
|
75 | 298 | 57 |
(no anchor)
https://insilico.com/
DOFOLLOW
|
|
insilico-medicine-completes-first-patient-first-dose-in-b...
https://medicaex.com/prnewswire/insilico-medicine-completes-first-patient-first-dose-in-bethesda-a-phase-ii-trial-for-garutadustat-ism5411-the-gut-restricted-ai-driven-phd-inhibitor-for-the-treatment-of-inflammatory-bowel-diseas
medicaex.com
|
51 | 7 | 9 |
(no anchor)
http://www.insilico.com/
NOFOLLOW
|
|
pandaomics-identifies-duel-targets-of-aging-and-age-relat...
https://www.mishablagosklonny.com/2022/03/31/pandaomics-identifies-duel-targets-of-aging-and-age-related-diseases
mishablagosklonny.com
|
— | 0 | 453 |
Insilico Medicine
https://insilico.com/
DOFOLLOW
|
|
pandaomics-identifies-duel-targets-of-aging-and-age-relat...
https://www.mishablagosklonny.com/2022/03/31/pandaomics-identifies-duel-targets-of-aging-and-age-related-diseases
mishablagosklonny.com
|
— | 0 | 453 |
PandaOmics
https://insilico.com/pandaomics
DOFOLLOW
|
|
pandaomics-identifies-duel-targets-of-aging-and-age-relat...
https://www.mishablagosklonny.com/2022/03/31/pandaomics-identifies-duel-targets-of-aging-and-age-related-diseases
mishablagosklonny.com
|
— | 0 | 453 |
consists
https://insilico.com/dual-purposetherapeutictargetspredictedusingai
DOFOLLOW
|
|
mysteries-of-the-human-genome-using-crispr
https://optimaclinical.com/mysteries-of-the-human-genome-using-crispr
optimaclinical.com
|
— | 0 | 7 |
Insilico Medicine
https://insilico.com/
DOFOLLOW
|
|
massachusetts-unicorns
https://www.failory.com/startups/massachusetts-unicorns
failory.com
|
72 | 190 | 2,471 |
Insilico Medicine
http://www.insilico.com/?ref=failory
DOFOLLOW
|
|
how-ai-and-longevity-biotechnology-are-revolutionizing-he...
https://www.mishablagosklonny.com/2024/11/06/how-ai-and-longevity-biotechnology-are-revolutionizing-healthcare-for-healthier-longer-lives
mishablagosklonny.com
|
— | 0 | 453 |
Insilico Medicine AI Limited, Masdar City, Abu Dhabi
https://insilico.com/
DOFOLLOW
|
|
generativeai
https://nicoras.net/2023/07/08/generativeai
nicoras.net
|
— | 0 | 2,257 |
https://insilico.com/
https://insilico.com/
DOFOLLOW
|
|
12810
https://aitimes.media/2023/02/09/12810
aitimes.media
|
60 | 8 | 272 |
Insilico Medicine
https://insilico.com/
DOFOLLOW
|
Frequently Asked Questions
How many backlinks does insilico.com have?
The backlinks page for insilico.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on insilico.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to insilico.com dofollow or nofollow?
Backlinks to insilico.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.